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The class II genes of the major histocompatibility complex (MHC) encode a
set ofcell surface glycoproteins that are involved in several aspects of the immune
response . The class II antigens, also called la antigens, are characterized by a
high degree of allelic polymorphism and are expressed primarily on B lympho-
cytes, antigen-presenting cells (i.e ., macrophage, dendritic cells), and human
activatedT lymphocytes. At least three distinct class II antigens exist in humans ;
these are designated HLA-DR, -DQ, and -DP (1). Each consists of two noncova-
lently linked subunits, the a chain (-35 kD) and the /3 chain (~29 kD) . In
addition, a third chain of -33 kD, called the invariant (In)' chain, is transiently
associated with the a and /3 subunits during their transport to the cell surface (2,
3, reviewed in reference 4) . The In chain is released from the a,# dimer after
the three chains have been through the Golgi complex . Most of the class II
antigens at the cell surface are not associated with In chain, except for a small
fraction that is associated with a proteoglycan derivative of the In chain (5) . The
fate of the In chain, as well as its role, remains unknown . However, because it is
always present in cells expressing class II antigens, and because of its physical
association with class II antigens, it has been postulated, and widely assumed,
that the In chain plays a role in assembly or transport of the a and # chains of
class II antigens .
The isolation of mAb specific for the In chain (6, 7), as well as cDNA clones
encoding the In chain (8-10), made it possible to analyze the In chain directly
rather than through its association with class II antigens. Expression of the In
chain in a variety of cell lines is inducible by IFN-1', with induction kinetics
similar to those of class II antigens (11), suggesting common regulatory pathways
for In chain and class II gene expression, although the In chain gene is not
located in the MHC (8, 12). However, la- B cell variants (13, 14) and la- B cells
from patients with congenital immunodeficiency (15) express In chain mRNA
but no mRNA from the class II genes . In these cases, therefore, a regulatory
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defect affects the class 11 genes independently of the In chain gene. In addition,
certain class 11-negative cells such as pre-B lymphomas, plasmacytomas, and
fibroblasts express some In chain (16).
The role of In chain has already been addressed in two experimental systems
without conclusive results. It was shown that a and ,Q chains of class 11 antigens
assemble in frog oocytes injected with mRNA for DRa and DR# in the absence
of In chain mRNA (8, 17). Unless the frog oocytes provide an analogous protein,
this result ruled out an absolute requirement for In chain in assembly of a,6
dimers. Second, mouse L cells transfected with the murine A. and As genes
expressed I-A antigen at their surface (18). However, it turned out that L cells
synthesize some In chain (16), making them unsuitable recipient cells for an
analysis of the In chain role. In order to test whether there is an absolute
requirement of the In chain for expression of class 11 antigens, we chose as
transfection hosts cell lines that do not express any detectable endogenous In
chain. These lines were transfected with cDNA clones encoding the a, #, or In
chains . These cDNA clones had been constructed in an expression vector
containing a simian virus 40 (SV40) promoter (19). The simian cell line COS
was used to obtain transient expression, whereas stable expression of the DR
antigen in absence of In chain was achieved by transfection of a human fibroblast
cell line. Our results indicate that cDNAs encoding class 11 MHC antigens can
be used successfully for cell surface expression. Most importantly, class 11 MHC
antigen expression can occur in absence of In chain.
Materials and Methods
Cells. The human lymphoblastoid cell line 45.1 (20) was cultured in RPMI 1640
supplemented with 15% FCS (Hazelton Dutchland, Inc., Denver, PA) and 2 mM gluta-
mine. The African green monkey kidney cell line COS and the human cell line HeLa
were cultured in DMEM supplemented with 10% FCS and 2 mM glutamine. SV40-
transformed human fibroblast 637B cell line (Human Genetics Mutant Depository, Cam-
den, NJ) was cultured in Eagle's MEM supplemented with 15% FCS and 2 mM glutamine.
African green monkey peripheral blood lymphocytes were obtained using a Ficoll-Paque
gradient (lymphocyte separation medium; Bionetics, Kensington, MD). Briefly, 100 ml of
heparinized blood was diluted with DMEM, layered on top of 15 ml of lymphocyte
separation medium and centrifuged for 15 min at 800 rpm at room temperature. The
interface was harvested and cells were washed twice with DMEM/10% FCS.
Antibodies.
￿
DR-FITC (Becton, Dickinson & Co., Palo Alto, CA), Leu-10-FITC (Becton,
Dickinson & Co.), and B7-21 are mouse mAb that are respectively directed to determinants
of DR (21), DQ (22), and DP (23). For immunoprecipitations the mAb D1-12, D4-22
(24), and BT2.9 (25) directed against monomorphic determinants of DR antigens were
used.
Plasmids.
￿
All the plasmids used in the transfection experiments were isolated from a
cDNA library constructed from mRNA of a human B cell line (19). The cDNA library
was made in an expression vector carrying the SV40 early promoter and SV40-derived
transcription termination sequences. The inserts of the clones encoding the ,8 chains of
DR, DP, and DQ antigens have been completely sequenced (19). The inserts of the clones
encoding the a chains of the DR, DQ, and DP antigens, as well as the In chain, were
sequenced at the 5' end to ensure that they started upstream of the ATG translation
initiation codon. The DRa insert follows a GC tail of 16 by and contains 73 by of 5'
untranslated sequence. The DQce insert follows a GC tail of 15 by and contains 50 by of
5' untranslated sequence. The DPa insert follows a GC tail of 16 by and contains 70 by
of 5' untranslated sequence. The In chain insert follows a GC tail of 14 by and starts at1492
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the nucleotide position 9 of the mRNA sequence as determined by primer extension (26).
The sequence of these cDNA clones will be described elsewhere. As a control plasmid for
the transfection experiments, a cDNA clone encoding the human J chain (27) was used
which had been isolated from the same cDNA library.
The DNA fragments used as probes in the hybridizations were derived from the
plasmids DRa-10 (28), DROII (29), and p33-1 (26).
Hybridizations.
￿
For Northern blots (30), RNA was denatured with glyoxal, size-frac-
tionated in 1.5% agarose gels (31),and transferred to diazobenzyloxymethyl (DBM) paper
(Schleicher & Schnell, Inc., Keene, NH). After a prehybridization in 50% formamide,
0.75 M NaCl, 25 mM sodium phosphate (pH 7.0), 5 mM EDTA, 0.02% polyvinylpyrrol-
idone, 0.02% Ficoll, 1% glycine, 0.2 mg/ml sonicated and denatured salmon DNA, and
0.5% SDS for 2 h at 42 °C, the filters were hybridized overnight at 42 °C in the same
solution but without glycine and with 10% dextran sulfate and 2 X 106 cpm/ml of
denatured nick-translated probe. The final wash was in 15 mM NaCl, 1 mM sodium
phosphate (pH 7.0), 1 mM EDTA, and 0.1% SDS at 65°C for 30 min unless otherwise
indicated. The probes were a 868-bp Pst I fragment of the In chain cDNA clone p33-1,
a 550-bp Pst I fragment of the DRa cDNA clone DRa-10, a 520-bp Pst I fragment of the
DR(O cDNA clone DR#11, and a 1.8-kb Hind III-Bgl II fragment containing the first
three exons of the HLA-A3 class I gene (32).
DNA-mediated Gene Transfer.
￿
All COS and 637B transfections were carried out by the
calcium phosphate coprecipitation technique (33). In a typical experiment, 106 COS or
637B cells plated 24 h earlier in a 100-mm petri dish were transformed with 10 Ag of
supercoiled DNA of each a, /3, In, or J chain plasmids. For stable transfections, 10 wg of
the pSV2-neo plasmid was also added (34). Calcium phosphate-precipitated DNA in 1 ml
was added to 5 ml DMEM/10% FCS in the petri dish and left with the cells for 16-20 h.
At this time the cells were washed with DMEM and a 1-min 15% glycerol shock was
applied (35). Cells were then washed three times with DMEM and incubated at 37°C in
DMEM/10% FCS. For transient expression assays, cells were harvested 48 h later. For
stable transfections, G-418 selection (1 mg/ml) was applied 48 h after initiation of the
transfection and the medium was washed every 2-3 d.
Cell Sorter Analysis.
￿
Adherent COS or 637B cells were detached from petri dishes
after incubation in Versene for 5 min at room temperature. Recovered COS cells or G-
418-resistant 637B cell populations were washed in ice-cold medium containing 2% heat-
inactivated serum. Transfectants were stained with either anti-class II mAb and fluores-
ceinated affinity chromatography-purified goat anti-mouse immunoglobulin (Becton,
Dickinson & Co.) or FITC-labeled anti-class II mAb as previously described (25). Cells
were washed twice with DMEM/2% FCS at 4°C and resuspended at 10' cells/ml in
PBS/2% FCS. Fluorescence analysis and asceptic cell sortingwere performed on an EPICS
V (Coulter Electronics, Inc., Hialeah, FL) flow microfluorometer with log amplifier. Live
cells were gated by forward light scatter as previously described (25). Data from analytical
microfluorometry are displayed as graphs of cell number versus fluorescence intensity
shown on a log scale. Every 85 channels represent a 10-fold increase in fluorescence
arbitrary units. A minimum of 104 cells were analyzed per population for each determi-
nation ofclass II expression . Forpreparative cell sorting, sterilestainedcellswere analyzed
for DR expression, and the brightest 5% cells isolated and regrown in selective medium.
Homogeneous cell lines were obtained by subcloning using an auto-clone (Coulter Elec-
tronics, Inc.) single-cell deposition system.
Radiolabeling and Immunoprecipitating of the DR Molecules.
￿
Transfected COS cells and
the 45.1 B cell line were labeled for 6 h at a density of 1.5 X 106 or 5 X 106 cells/ml,
respectively, in DMEM lacking methionine and supplemented with 0.5% FCS, 2 mM
glutamine, and ["Slmethionine (1,000-1,400 Ci/mmol; Amersham Corp., Arlington
Heights, IL)at 250 ACi/ml. Afterlabeling,cell pellets were solubilized in buffer containing
10 mM Tris-HCI, pH 7.4, 0.15 M NaCl, 0.0015 M MgC12, 0.5% NP-40, and the protease
inhibitors PMSF (200 ug/ml; Sigma Chemical Co., St. Louis, MO) and 0.1% aprotinin
(Sigma Chemical Co.) . Lysates were spun for 1 h at 60,000 gin a SW 50Ti rotor (Beckman
Instruments, Inc., Palo Alto, CA). The supernatant of the lysate was adjusted to pH 8.0SEKALY ET AL .
￿
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FIGURE 1 .
￿
Lack of In chain mRNA in different cell lines . Total RNA from the indicated cell
lines was size-fractionated by gel electrophoresis and transferred to DBM-paper . RNA from
the B cell line 45 .1 was serially diluted into HeLa cell RNA in 10-fold increments. 20 /ag of
RNA was loaded in each lane . Hybridization was with a nick-translated fragment from the In
chain cDNA clone p33-1 . The final wash was in 37.5 mM NaCI, 5 mM sodium phosphate (pH
7.0), 1 mM EDTA, and 0.1% SDS at 65°C for 30 min . At this stringency the p33-1 probe
hybridizes weakly with 28 SrRNA. This hybridization was also observed with poly(A)- RNA
and was reduced by washes at higher stringencies . The position of 18 S and 28 S RNA is
indicated on the left .
with 6 ul of 1 M NaOH and to 1% aprotinin . Samples were incubated at 4° C for 4 h with
8 jl of anti-SV40 antisera (a gift ofH . Turler) and 8 Al of BALB/c serum, followed by a
2-h incubation with protein A-Sepharose (Pharmacia Fine Chemicals, Uppsala, Sweden) .
Samples were spun down and supernatants were incubated overnight at 4°C with 24 U1
of ascitic fluids from a pool of anti-DR mAb . Samples were spun for 3 min in the
Eppendorf microfuge (Brinkman Instruments, Westbury, NY) and the pellets were dis-
carded . Protein A-Sepharose was added to the supernatant and incubation was continued
for 4 h . Immunoprecipitates were washed twice in 50 mM sodium phosphate (pH 8.3), 5
mM EDTA, 0.15M NaCl, 1% NP-40, 10mM methionine, and 1% aprotinin, three times
in the same buffer without aprotinin and with 0.5 M NaCl and twice in 50 mM sodium
phosphate (pH 8 .3), 1 mM EDTA, 0.15 M NaCl, and 0.5% NP-40 . Two-dimensional gel
electrophoresis, with nonequilibrium pH gradient electrophoresis in the first dimension,
was run according to O'Farrell et al . (36) . The second dimension was in 12% polyacryl-
amide gels . Gels were fixed in 10% TCA, treated with Enhance (New England Nuclear,
Boston, MA) washed in 20% methanol and 3% glycerol, and dried . Dried gels were
exposed to Kodak XS-5 film, with intensifying screens at -70 °C .
Results and Discussion
The role of the In chain was investigated by transfecting the genes for the a,
(3, and In chains of human class II MHC antigens into cell lines that are not
expressing In chain. Several cell lines known to be efficient recipients for DNA
were first tested for the presence of endogenous In chain RNA. The human
cervical carcinoma line HeLa and the human fibroblast line 637B were tested,
as well as the African green monkey kidney line COS (Fig . 1) . To define the
detection limit of the experiment, RNA from the EBV-transformed B lympho-1494
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FIGURE 2.
￿
Cell surface expression of MHC class II genes cotransfected with or without In
chain in COS cells. 10 ug of each plasmid were transfected in COS cells using the CaP04
precipitation technique. To keep the amount of DNA constant, 10 wg of a plasmid with a
cDNA encoding the humanJ chain (27) was cotransfected whenever the In chain wasabsent.
Cells were harvested 72 h after transfection, stained by direct immunofluorescence with a
mAb to a monomorphic determinant of DR, and analyzed on a flow microfluorometer. The
same transfection procedure was repeated in COS cells with plasmids carrying the DQa and
DQS cDNA (ef) or the DPa and DPt3 cDNAs (h-i). In each case these plasmids were
transfected with (e and h) or without (f-i) In chain cDNA. The cell surface expression of
MHCclass II molcules on thesurface of transfected cellswas compared to that of a Bcell line
45 .1 (a, d, andg). Each panelrepresents acomparison between the indicatedcellsstained with
the relevant mAb(open triangle), (open square) or with an irrelevant mAb (open circle). 10,000
viable cells were accumulated foreach histogram.
blastoid cell line 45 .1, which expresses In chain RNA, was serially diluted into
HeLa RNA and included in the same gel. The results show that, if any In chain
RNA is present in HeLa, 63713, or COS cells, it would have to be <10-'the level
foundin B cells. The stringency of thehybridization was chosen to allow detection
of the simian In chain RNA with the human probe (see below). We concluded
that the three lines, HeLa, 63713, and COS were suitable recipients for our
experiments in that they express insignificant amounts of In chain RNA, if any.
Cell SurfaceExpression ofClassII MHC Antigens in Transfected COS Cells.
￿
COS
cells carry integrated copies of the SV40 T antigen gene (37). Plasmids carrying
the SV40 origin of replication replicate in COS cells. We chose to test the COS
system for expression of class II MHC antigen cDNA clones that had been
constructed in an SV40-derived vector (19). cDNA clones encoding the DRa,
DRO, and In chains were introduced into COS cells by the calcium phosphate
precipitation technique (33). 3 d after transfection, cells were analyzed for the
presence ofsurface DR antigenby flow cytometry usingamAbto amonomorphic
determinant of DR. The histograms (Fig. 2b) show a bimodal distribution with
a majority of cells (>_70%) expressing low but significant amounts of DR antigen,
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and a smaller proportion of cells (25 .7%) expressing levels of DR antigen
comparable to those observed in a B cell line (Fig. 2a). We conclude that COS
cells have all the necessary components for the assembly and transport of class
II antigens, and that they provide a useful and rapid assay for cell surface
expression of class 11 antigens. Considering that no selection is applied, it is
remarkable that as many as 20% ofcells show bright fluorescence. Other studies
in COS cells with a single gene product expressed at the cell surface reported
10-20% of positive cells (38, 39). The requirement of In chain for cell surface
expression of human MHC class II molecules was investigated. When COS cells
were transfected only with DRa and DRO cDNA clones, they expressed DR
antigens at the cell surface with a similar bimodal distribution (Fig. 2 c). The
resultsofseveral experiments(Table I) indicated that any difference in the mean
fluorescence intensity or in the percentage ofbrightly fluorescent cells between
cells transfected with or withoutthe In chain was within experimental variability.
Therefore, unless endogenous In chain synthesis is induced in transfected COS
cells, assembly and transport to the cell surface of DR antigen do not require In
chain.
In order to test whether this lack of In chain requirement also held for other
class 11 antigens, cDNAs encoding the aand (3 chains ofthe DQ and DP antigens
were introduced into COS cells with or without the In chain. Transfectants were
analyzed by flow cytometry using antibodies specific for DQ and DP. The results
(Fig. 2 and Table 1) show that cell surface expression of DQ and DP antigens in
COS cells can occur in absence of In chain of human origin .
The In Chain Is Not Induced in Transfected COS Cells.
￿
RNA from transfected
COS cells was analyzed to test for the possibility of induction ofthe endogenous
In chain. RNA isolated from peripheral blood lymphocytes of African green
monkey was included as a positive control to show that the human DNA probes
for the a,a, and In chains did crosshybridize to their simian counterparts. These
RNA hybridizations also allowed determination ofthe size and abundance ofthe
transcripts derived from the cDNA expression vectors. These transcripts are
expected to be about 300 nucleotides longer than mRNAs transcribed in cells
naturally expressing class II antigens because they contain about 60 nucleotides
of the SV40 early leader, 45 nucleotides of a synthetic polylinker, and a G tail
that varies between 6 and 18 nucleotides upstream ofthe cDNA insert and about
185 nucleotides of SV40 sequences downstream of the poly(A) tail (19, 40).
mRNAs for the DRa, DRO, and In chains are all ^-1 .3 kb (13). Therefore,
transcripts from the SV40-derived expression vectors should be ^-1 .6 kb. Fig.
3A shows the hybridization with the DRa probe. The mRNA for the simian
DRa chain can be detected in the lymphocytes of African green monkey and is
of the same size as DRa mRNA from a human B cell line. As expected,
untransfected COS cells are negative. COS cells transfected with the DRa cDNA
cloneexpress high levels of DRa transcripts, most ofwhich are ^.1.6 kb. Discrete
bands at ^-3.5 kb and 4 kb are also detected. These longer transcripts could
result from transcription initiation or termination in the plasmid sequence, or
from recombination events between vectors. Hybridizations with the DR,# and
the In chain probes show similar results (Fig. 3B and C). The corresponding
mRNAs in the monkey cells are easily detected, and transfected COS cells show1496
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TABLE I
Cell Surface Expression of Class 11 Antigens in COS Cells
106 COS cells were transfected with the indicated plasmids in duplicate
or triplicate petri dishes. Cells were harvested 72 h later and stained
with mAb specific to DR or DP as described in Fig. 2. FAGS analysis
wasperformedas detailed in Materials and Methods.
* To maintain the totalamount oftransfected DNAconstant, an irrelevant
plasmid was added in the transfections that did not include theIn chain
(experiments 1 and 3). To rule out a possible artefact caused by the
irrelevant plasmid, transfections were also carried out with only the a
and S chain plasmids (experiments 2 and 4).
$ 10 jug of each plasmid was used, except when the In chain plasmid was
transfected alone in which case 30 ag was used. Thejchain plasmid was
isolated from the same cDNA library and is described in Materials and
Methods.
§Themean fluorescence is expressedin channelnumbers(arbitrary units).
A twofold increase in fluorescence represents a shift of 25 channels.
primarily 1.6-kb transcripts with some 3.5- and 4-kb transcripts. Most impor-
tantly, COS cells transfected only with the DRa and DR# vectors show no
detectable In chain RNA. From these results we may conclude that the In chain
is not necessary for cell surface expression of DR antigens.
The levels of DRa, DRO, and In chain transcripts in transfected COS cells are
comparable to those found in B cells (Fig. 3). In contrast, the average level of
cell surface DR antigens is much lower in transfected COS cells than in B cells
(Fig. 2). Several reasons could account for the apparent inefficiency of cell
surface DR antigen expression in COS cells. First, the recombinant RNA tran-
Exp.* Plasmids$ Mean
fluorescence$
Percent of
cells above
channel 60
1 DRa, DRS, In 56.8 31 .6
52 .0 27.0
40.8 16.2
1 DRa, DRS, J 51 .0 25.7
49.9 28.2
39.4 20.5
1 In 16.7 1.5
2 DRa, DRQ, In 48 .7 21 .5
47.5 19.6
2 DRa, DRS 47 .0 20.5
45 .8 22.3
2 In 10.0 2.0
3 DRa, DRS, In 49 .8 23.0
47 .1 24.3
41 .6 20.3
3 DRa, DRS, J 44.6 20.8
47.4 26.4
46.2 22.5
3 DPa, DPS, In 57 .1 40.1
3 DPa, DPS, J 59.3 37.6
3 In 15 .1 1.0
4 DPa, DPS, In 51 .7 27.3
4 DPa, DPS 49 .6 21.3
50.4 24.5SEKALY ET AL .
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FIGURE 3 .
￿
Northern blot analysis oftransfected and untransfected cells . 20 gg of total RNA
from the indicated cells was size-fractionated by gel electrophoresis and transferred to DBM
paper . 45.1 is a human EBV-transformed B cell line ;AGMPBL are peripheral blood lympho-
cytesfrom African green monkey ; COSare COS cells either untransfected or transfected with
plasmids carrying cDNA for DRa (a), DR# (fl), and In chain (Inv) in the combinations
indicated . The filters were hybridized with nick-translatedDNA fragments from DRacDNA
(A), DR,# cDNA (B), In chain cDNA (C), and an HLA-A3 gene (D) . Hybridization with the
class I probe (D) served to show that the RNA from untransfected COS cells was intact . The
final wash was in 37.5 mM NaCl, 5 mM sodium phosphate (pH 7.0), 1 mM EDTA, and 0.1%
SDS at 65 °C for 30 min . The position of 18 S and 28 S RNA is indicated at the left of each
panel .
scripts may be translated inefficiently because of the artificial 5' and 3' untrans-
lated sequences. Second, transfected COS cells may be inherently inefficient in
the posttranscriptional steps required . Finally, translation of the In chain may
not occur in cells transfected with the In chain cDNA . Therefore, experiments
were carried out to test for translation of the In chain in transfected COS cells .
Expression ofIn Chain Proteinfrom Its cDNA in COS Cells .
￿
It was important to
test whether the In chain cDNA was expressed and whether its product would
associate with intracellular a/3 dimers . For this purpose, immunoprecipitation of
the DR molecules in cells biosynthetically labeled with ["S]methionine was
carried out using an mAb specific for DR antigens (Fig . 4) . DR antigens
immunoprecipitated from a control human B cell line show a characteristic
pattern of spots on a two-dimensional gel. The DRa and DRO chains appear as
multiple spots, owing to processing of the glycosyl groups . The In chain, which
is precipitated by virtue of its association with DR molecules, appears as a1498
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FIGURE 4.
￿
Two-dimensional gel analysis ofHLA-DR antigens immunoprecipitated from a B
cell line and from transfected COS cells . Cells were labeled with [sSSlmethionine for 6 h . DR
antigens were immunoprecipitated with apool of mAbs, D1-12, D4-22, andBT2.9 . Thearrow
indicates the position of the p33 In chain . Brackets indicate the position ofa chain spots, S
chain spots, and the basic p35 spots that are related to the p33 In chain . To facilitate
comparisons the arrows and brackets have been placed at identical positions in the different
panels . (A) B cell line 45 .1 ; (B) COS cells transfected with DRa, DRS, and In chain cDNA
clones ; (C) COS cells transfected with DRa and DRS chain cDNA clones ; (D) COS cells
transfected with the In chain cDNA clone .
prominent spot of 33 kD (p33), with a row of more acidic spots that extends to
the DRa chain position, and with two additional, more basic spots of 35 kD
(p35) . In COS cells transfected with cDNAs for the DRa, DRa, and In chains, a
similar pattern of spots is observed . Therefore translation of these three chains
occurs with fidelity in COScellseven though the relative intensity of the differentSEKALY ET AL.
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spots is not identical. It is also evident that the amount of In chain associated
with DR a# complexes in COS cells is lower than that in B cells. This is not a
surprising result because B cells produce much more In chain than they do DRa
and DR# chains (41), whereas transfected COS cells produce equivalent levels of
RNA for each chain. We cannot predict how DR expression in COS cells would
be affected if much higher levels of In chain could be produced.
Immunoprecipitations from COS cells transfected with only DRa and DRa
chains show the typical a and fl spots, and no material at the position of the In
chain spots. Assembly and processing of the a# dimers therefore proceed in
absence of the In chain. Processing of a# dimers in presence or absence of the
In chain was investigated in another study in which mRNAs for the DRa, DR#,
and In chains were injected in frog oocytes (17). Although the a and 0 chains
assembled in the absence of the In chain, it appeared that their transport was
slowed and that their glycosylation patterns were incomplete. Our experiments
do notaddressdirectly the question ofthe rate of transportand thefine specificity
of posttranslation modifications. Although these parameters could be affected
by the In chain, it is clear from our data that the In chain is not an absolute
requirement for cell surface expression of DR antigen.
Transfected Human Fibroblasts Express DR Antigens in the Absence of the In
Chain. The expression of transfected genes in COS cells is transient. Further-
more, translation efficiency of class II antigens is much lower in transfected COS
cells than in B cells. To test whether the In chain was necessary for cell surface
expression of class II antigens in a stable expression system, we analyzed the
human fibroblast line 637B, which had been transfected with the cDNA clones
for the DRa, DR#, and In chains together with the plasmid pSV2-neo (34), which
allows selection with the neomycin analog G-418. G-418-resistant colonies were
pooled 3 wk after selection and were stainedwith a mAb specific for DR antigens.
Preparative cell sorting was used to isolate a homogeneously positive population
of cells. The 637B clone C9 and its subclones C9B5 and C9E8 express levels of
DR antigen which are 3-10-fold lower than those found on a B cell line (Fig. 5).
Because the frequency of cells positive for DR antigens was very low among
the G-418-resistant 637B cells, we reasoned that the efficiency of cotransfection
with unlinked genes might be low. As a result, it was likely that a gene that was
not under selection would not be expressed in the transfected cells. In order to
test this possibility, we analyzed RNA from the cloned transfectants for the
presence of In chain transcripts. The results (Fig. 6) showed that the 637B-C9
clone, as well as its subclones, does not express detectable In chain RNA.
Therefore, the cDNA clone for the In chain was either not retained or not
expressed in the transfected cells. This experiment also shows that the endoge-
nous In chain gene is not induced in 637B cells as a result of transfection with
class II genes. It was an important control because the In chain gene in 637B
cells is inducible by treatment with IFN-7 (Fig. 6). Hybridizations with DRa and
DR,# probes (data not shown) showed the expected 1 .6-kb transcripts in the
transfected 637B-C9 cells. However, the levels of DRa and DR#transcripts were
much lower than in COS cells. Unlike COS cells, transfected 637B cells lacking
In chain are therefore quite efficient in the posttranscriptional steps of DR
antigen expression . The results obtained with 637B cells confirm and strengthen1500
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FIGURE 5.
￿
Cell surface expression of DR antigens in ahumanfibroblast line transfected with
cDNA clones. Cloned stable transfectants of the fibroblast line 637B expressing DR antigens
were obtained as described in Materials and Methods. Three of these clones (panels b-d) were
stained with a mAbto DR and compared with a B cell line (panel a). Each panel represents a
comparison between the indicated cells stained with the relevant mAb (open triangle) or with
an irrelevant mAb (open circle). 10,000 viable cells were accumulated for each FACS histogram .
the conclusion derived from the COS cell transfections because they show that
constitutive and efficient cell surface expression of DR antigens can occur in
absence ofthe In chain.
Conclusions. This report demonstrates that class II MHC antigens can be
expressed at the surface of simian and human cells in absence of the In chain.
The In chain, which is associated with class II antigens in the cytoplasm of
natural class II-positive cells, istherefore not required for assembly and transport
ofclass II a and ß chains. Unless the association of the In chain with class II aß
dimers is fortuitous, this conclusion suggests an interesting alternative, namely,
that the Inchain is involved in the function ofclass II MHC antigens . Presentation
of foreign antigens to class II-restricted T lymphocytes requires processing of
antigen and most likely a direct interaction between specific peptides and class
II antigens (42, 43). The nature ofthis interaction and the mechanisms by which
it occurs are unknown, but important steps probably take place inside the cell.
Recycling ofclass II antigens into the cell may be necessary forantigen processing
and presentation. It is easy to imagine a role for the In chain in these intracellular
events. Cresswell (44) has shown that class II antigens on their way to the cell
surface intersect the pathway taken by endocytosed transferrin receptors before
dissociation of the In chain. Therefore, class II a0In complexes could interact
with internalized foreign antigens in antigen-presenting cells.
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FIGURE 6 .
￿
The DR' transfected cell 637B does not express the In chaingene . 20 Wg of total
RNA from the indicated cells was size-fractionated by gel electrophoresis and transferred to
DBM paper . 45.1 is ahumanEBV-transformedB cell line. 637B is ahuman SV40-transformed
fibroblast that was grown in absence or in presence (+ Y-IFN) of rIFN- ,y (a gift of N. Sarvar,
Meloy Laboratories, Springfield, VA) . C9 is a clone of 637B cells transfected with HLA-DR
genes . C9B5 andE9E8 are subclonesofC9 . (A) The filter washybridized with a nick-translated
DNA fragment from the In chain cDNA . (B) The filter shown inA was rehybridized with a
nick-translated DNA fragment from the HLA-A3 gene . The arrowhead points to the residual
signal from the In chain probe . Hyl2ridization with the class I probe served to show that the
RNA from all cell lines was intact. The positions of 18 S and 28 SRNA are indicated on the
left .
The major conclusion from our study is that, rather unexpectedly, association
with In chain is not a requirement for cell surface expression of class II a#
heterodimers . The availability of transfected cells expressing class 11 antigens in
absence of In chain and of an expressible In chain cDNA makes it possible to
test what role the In chain might play .
Summary
The invariant chain is a glycoprotein transiently associated with the a and a
subunits of class 11 antigens of the major histocompatibility complex during their
transport to the cell surface . An expression assay with cDNA clones transfected
into simian COS cells was used to test whether the invariant chain is required
for assembly and transport of human class II antigens . COS cells do not express
detectable levels ofRNA from the endogenous invariant chain gene . Cell surface
expression of the DP, DQ, and DR antigenswas observed inCOS cells transfected
with the respective a and a chain cDNA clones . Analysis of RNA from the
transfected cells showed that the human genes were transcribed in COS cells and
that the endogenous simian class 11 and invariant chain genes were not induced.
Cotransfections with an invariant chain cDNA clone did not alter the levels of
class 11 antigens at the cell surface . Biosynthetic labeling and immunoprecipita-150 2
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tion demonstrated that the invariant chain cDNA was expressed into a protein
which associated with DR a and a chains. Efficient expression of DR antigen in
absence of invariant chain was also observed at the surface of a human fibroblast
line stably transfected with DR a and /3 cDNA. This study demonstrates that
expression of all three human class II antigens can be achieved with cDNAs
cloned in expression vectors. Furthermore, cell surface expression of class II
major histocompatibility complex antigens can occur in absence of invariant
chain. The postulated role of the invariant chain in class II antigen transport to
the cell surface must be reevaluated. The invariant chain may rather be involved
in functional properties of class II molecules such as antigen presentation.
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Note addedin proof Results similar to those described here have been obtained by Miller and Germain
(45) with transfections of murine la antigen genes.
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